BlueRock Therapeutics
Emily Robbins, Ph.D., is a Scientist II in Manufacturing Sciences & Technology at BlueRock Therapeutics, where employment began in September 2021 after progressing through roles including Scientist II and Scientist I in Process Development. Prior to BlueRock, Emily was a Biomedical Engineering PhD candidate at Worcester Polytechnic Institute, conducting research on decellularized plant scaffolds for cardiac tissue engineering. Additional experience includes an internship at Bristol Myers Squibb in Upstream Manufacturing Science & Technologies, and a Clinical Engineer position at Materialise, where collaboration with craniomaxillofacial surgeons involved designing patient-specific 3D printed surgical guides. Previous roles include Orthopaedics Research Engineer at Rhode Island Hospital with an emphasis on ACL injury research, and engineering internships at Hstar Technologies and Simbex. Educational qualifications include a PhD in Biomedical Engineering from Worcester Polytechnic Institute, a Master of Engineering from Tufts University, and a Bachelor of Science from the University of Rochester.
This person is not in any teams
This person is not in any offices
BlueRock Therapeutics
2 followers
BlueRock Therapeutics: Repairing the body when it cannot repair itself